ADVFN US – Market Content Editor

  • Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger

    Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger

    Aethlon Medical (NASDAQ:AEMD) shares surged more than 400% in pre-market trading on Thursday after the company announced a definitive merger agreement with privately held biotechnology company North Immunology. The all-stock transaction will combine the businesses through Aethlon’s wholly owned subsidiaries, Nighthawk Merger Sub Corp. and Nighthawk Second Merger Sub, LLC. Following completion, the combined company…

  • CoreWeave Signs New Compute Contracts at Approximately $40 Million per Megawatt

    CoreWeave Signs New Compute Contracts at Approximately $40 Million per Megawatt

    CoreWeave (NASDAQ:CRWV) has reported signing new computing capacity contracts at higher prices since 30 June 2026, as the company expands its commitments to customers requiring artificial intelligence infrastructure. During the third quarter of 2026, CoreWeave entered into short-term customer agreements lasting approximately three to six months, with pricing equivalent to around $40 million per megawatt.…

  • Qiagen Shares Rise 4% Following Report of Private Equity Takeover Interest

    Qiagen Shares Rise 4% Following Report of Private Equity Takeover Interest

    Qiagen (NYSE:QGEN) shares gained 4% on Thursday morning following a media report that several private equity firms are considering potential offers for the molecular testing company. German publication Manager Magazin reported that TPG and Bain Capital are among the firms weighing bids for Qiagen, although it did not identify sources for the information. The report…

  • Novo Nordisk Publishes Phase 3b Denecimig Results in Haemophilia A

    Novo Nordisk Publishes Phase 3b Denecimig Results in Haemophilia A

    Novo Nordisk (NYSE:NVO) has published results from its phase 3b FRONTIER5 study of investigational treatment denecimig in the Journal of Thrombosis and Haemostasis, reporting safety, laboratory and patient-experience findings in people with haemophilia A. The study examined whether patients could switch directly from emicizumab to denecimig without requiring a washout period or an initial loading…

  • Barrick Mining Shares Rise 1.2% Following New Buy Rating and Gold Price Recovery

    Barrick Mining Shares Rise 1.2% Following New Buy Rating and Gold Price Recovery

    Barrick Mining Corporation (NYSE:B) shares gained 1.2% to $43.06 in pre-market trading following the initiation of coverage with a Buy rating, as gold prices recovered above $4,300 per ounce. The new analyst recommendation coincided with a price target revision from Bernstein, which lowered its target for Barrick to $56.50 from $61. Both developments came as…

  • Vicor Shares Rise 11% Following AI Power Delivery Technology Licensing Agreement

    Vicor Shares Rise 11% Following AI Power Delivery Technology Licensing Agreement

    Vicor (NASDAQ:VICR) shares climbed 11% on Thursday morning after the company announced a non-exclusive licensing agreement for its Vertical Power Delivery (VPD) technology with a leading artificial intelligence original equipment manufacturer (OEM). The agreement allows the unnamed manufacturer to purchase VPD modules covered by Vicor’s patents from suppliers that do not hold their own licences.…

  • USA Rare Earth, Pasqal and Riven Systems Partner to Develop Rare Earth Separation Technology

    USA Rare Earth, Pasqal and Riven Systems Partner to Develop Rare Earth Separation Technology

    USA Rare Earth (NASDAQ:USAR), Pasqal (NASDAQ:PSQL) and Riven Systems have announced a strategic partnership to develop technology aimed at improving the separation of rare earth elements. The collaboration, announced on 17 September 2026, will combine Pasqal’s neutral-atom quantum computing technology, Riven Systems’ automated chemistry laboratory and USA Rare Earth’s mineral processing expertise. The companies intend…

  • Newmont Shares Rise 1.5% as Gold Prices Recover and Analysts Raise Price Targets

    Newmont Shares Rise 1.5% as Gold Prices Recover and Analysts Raise Price Targets

    Newmont (NYSE:NEM) shares gained 1.5% to $123.63 in pre-market trading as gold prices recovered towards $4,300 per ounce following an initial decline after the Federal Reserve’s latest interest rate increase. The US central bank raised its benchmark rate by 25 basis points on 16 September, bringing the federal funds target range to 3.75%–4.00%. The decision…

  • Nebius Shares Jump 11.1% Following GPU Cloud Service Price Increases

    Nebius Shares Jump 11.1% Following GPU Cloud Service Price Increases

    Nebius Group NV (NASDAQ:NBIS) shares surged 11.1% in pre-market trading after the company notified customers of price increases across its on-demand GPU cloud services, effective 1 October 2026. The adjustments include increases of approximately 17% for Nvidia H100 instances and 21% for the newer Nvidia B300 GPU. Rates for AMD EPYC Genoa CPUs will rise…

  • BCB Bancorp Shares Fall 4.9% After Stock Offering and Third-Quarter Loss Warning

    BCB Bancorp Shares Fall 4.9% After Stock Offering and Third-Quarter Loss Warning

    BCB Bancorp (NASDAQ:BCBP) shares declined 4.9% in pre-market trading after the New Jersey-based community bank announced a common stock offering, plans to sell a portfolio of problem loans and expectations for a substantial third-quarter loss. The company priced an underwritten public offering of 11 million common shares, targeting gross proceeds of $85.25 million before underwriting…